Our faculty members frequently make appearances in the media as expert consultants or authors. This article summarizes the faculty media appearances that were featured in our Department newsletter in October 2022.
UofT News. October 18, 2022. Featuring Dr. Ana Cristina Andreazza.
Dr. Andreazza assists U of T alum Angela Duong in creating 2D and 3D brain models to better identify biological targets that can be used in the development of therapeutics, and uses these models to further investigate a range of psychiatric conditions.
Global News. October 13, 2022. Featuring Dr. Michaela Beder.
Dr. Beder uses his expertise on immigration and severe mental illness to expand on the negative effects of the immigration system structure on the mental health of asylum seekers.
Common Sense. October 11, 2022. Featuring Dr. K. Sonu Gaind.
Dr. Gaind explores the nuances of the Medical Assistance in Dying Act (MAiD) and raises concerns on how it results in the deaths of marginalised Canadians whose psychosocial suffering could be alleviated in different ways.
Medscape Medical News. October 10, 2022. Featuring Dr. Ari Cuperfain.
Dr. Cuperfain investigates suicide notes left by elderly people in order to better understand the reasons for suicide attempts and to consequently decrease suicide risk in this vulnerable population.
Medscape Medical News. October 6, 2022. Featuring Dr. Roger McIntyre.
Dr. McIntyre discusses the strengths and weaknesses of a Cambridge study that investigates the relationship between long-term antidepressant use and its effect on patients’ susceptibility to cardiovascular disease.
Taproot Edmonton. October 5, 2022. Featuring Dr. Sanjeev Sockalingam.
Dr. Sockalingam speaks on the development of Calibre, his new program on obesity that takes into account the nuances of living with and treating obesity with input from people living with obesity.
Psychiatric Times. October 4, 2022. By Dr. Nicole Ledwos, Dr. Ishrat Husain, Dr. David J. Castle, and Dr. Tony P. George.
This group of researchers explore the use of psychedelic drugs in the treatment of mental health disorders in this new study, kickstarting a growing interest in the drugs’ medical potential.